Bio Solution Overview

  • Founded
  • 2000
Founded
  • Status
  • Public
  • Employees
  • 77
Employees
  • Stock Symbol
  • 086820
Stock Symbol
  • Share Price
  • $19.81
  • (As of Friday Closing)

Bio Solution General Information

Description

Biosolution Co Ltd is a Korean company offering Cell-Based Biotechnology. It is engaged in manufacturing and selling cell therapy products, and developing cell therapeutics technology. Its main areas include cell-based therapeutics with their background in somatic and stem cell technology, and the manufacturing, sales, and R&D of human tissue models for screening toxicity and efficacy with tissue engineering technology.

Contact Information

Formerly Known As
MCTT Co., MCT Bio
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Stock Exchange
KRX
Primary Office
  • Seoul Techno Park 5F
  • 232, Gongneung-ro, Nowon-gu
  • Seoul, Nowon-gu
  • South Korea
+82 00-0000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Bio Solution Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$19.81 $19.85 $17.41 - $34.57 $158M 7.97M 66.2K -$0.14

Bio Solution Financials Summary

In Thousands,
USD
TTM 31-Mar-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 155,569 183,326 260,925 185,152
Revenue 7,125 6,559 7,617 9,576
EBITDA (736) (1,173) 28 1,575
Net Income (1,104) (1,524) (598) 1,226
Total Assets 44,267 45,648 44,725 47,273
Total Debt 1,094 1,315 657 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Bio Solution Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Bio Solution‘s full profile, request access.

Request a free trial

Bio Solution Patents

Bio Solution Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210269766-A1 Cell culture medium for culturing extracellular vesicles at high concentration and method for preparing conditioned medium containing high concentration of extracellular vesicles using cell culture medium Pending 10-May-2019 0000000000
US-20210262908-A1 Size-based separation method for highly concentrating extracellular vesicle in fluid sample Pending 25-Jun-2018 0000000000
EP-3574892-A1 Cosmetic composition for wrinkle reduction or anti-inflammation, containing substance p Pending 14-Jun-2017 00000000
EP-3574892-A4 Cosmetic composition for wrinkle reduction or anti-inflammation, containing substance p Pending 14-Jun-2017 00000000 0
US-20210137809-A1 Cosmetic composition for wrinkle reduction or anti-inflammation, containing substance p Pending 14-Jun-2017 A61K8/731

Bio Solution Executive Team (3)

Name Title Board Seat Contact Info
Jung-Hyun Yoon Co-Chief Executive Officer & Director
Jung-Sun Lee Co-Chief Executive Officer, Head of Research & Director
Song-Seon Jang Chief Executive Officer & Board Member
To view Bio Solution’s complete executive team members history, request access »

Bio Solution Board Members (1)

Name Representing Role Since
Song-Seon Jang Bio Solution Chief Executive Officer & Board Member 000 0000
To view Bio Solution’s complete board members history, request access »

Bio Solution Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial